16 April 2021 | News
The US alone is expected to have at least 300 million excess doses of vaccine by the end of July 2021, according to new research released
Source credit: Shutterstock
Just 10 nations with less than half the world’s population are administering three-quarters of all COVID-19 vaccine doses, while the poorest countries have barely begun vaccinating due to lack of funding and supply. The US alone is expected to have at least 300 million excess doses of vaccine by the end of July 2021, according to new research released.
The new research paper outlines a three-part plan to strengthen US leadership for safe, effective, and equitable global vaccine access, which is needed urgently. The recommended approach combines:
The Gavi COVAX Advance Market Commitment (AMC) Investment Opportunity launch on Thursday, April 15th, co-hosted by the US, will provide an opportunity for the US to articulate more clearly its broader leadership role for the global response.
The paper is authored by Dr Mark McClellan, Director, Duke-Margolis Center for Health Policy and former US FDA Commissioner; Dr. Krishna Udayakumar, Director, Duke Global Health Innovation Center; Dr Michael Merson, prior Director of the WHO Global Programme on AIDS and prior founding Director of the Duke Global Health Institute; Gary Edson, President of the COVID Collaborative and former US Deputy National Security Advisor and Deputy National Economic Advisor; and Dr Scott Gottlieb, Resident Fellow at the American Enterprise Institute and former US FDA Commissioner.